Article
EGFR family signaling and its association with breast cancer development and resistance to chemotherapy (Review)
1 Feb 2003
Abstract excerpt
Epidermal growth factor (EGF) receptors (EGFRs) and signaling pathways activated by these receptors have been associated with development of breast cancer as well as its resistance to treatment with cytotoxic drugs. This review describes the current understanding of EGFRs and their downstream signaling pathways. Emphasis is placed upon Raf/MEK/ERK and PI3K/PDK1/Akt signaling pathways and their relationship to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
